ERNA vs L · P/E 0.0, rev $582.0K vs P/E 14, rev $18.45B
Eterna Therapeutics Inc (ERNA) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the ERNA and L stock pages for the full models.
Not investment advice.